HCP PLASTENE BULKPACK LIMITED (HPBL.BO)
INR 105.0
(2.39%)
INR 105.0
(2.39%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -324.68 Million | -293.81 Million | -267.04 Million | -170.34 Million | 6.05 Million | 327.95 Million |
| Net Income | -11.86 Million | -22.12 Million | -30.47 Million | 636.23 Million | -207.03 Million | -890.08 Million |
| Depreciation & Amortization | 72.97 Million | 73.87 Million | 52.41 Million | 51.22 Million | 57.59 Million | 60.04 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -383.85 Million | -329.07 Million | -293.63 Million | -140.67 Million | 158.96 Million | 890.2 Million |
| Other non-cash items | 249.28 Million | 296.71 Million | 95.97 Million | -535.39 Million | 128.48 Million | -50.65 Million |
| Investing Cash Flow | -36.96 Million | -97.51 Million | -462.73 Million | -7.98 Million | 4.21 Million | -29.75 Million |
| Investments in PPE | -43.33 Million | -144.75 Million | -578.56 Million | -10.44 Million | - | -33.96 Million |
| Acquisitions | 6.2 Million | 44.59 Million | 118.83 Million | 1.38 Million | 4.07 Million | 3.56 Million |
| Investment purchases | - | - | -3 Million | - | - | - |
| Sales/Maturities of investments | 163 Thousand | 698 Thousand | - | - | 148 Thousand | 646 Thousand |
| Other Investing Activities | - | 1.95 Million | - | 1.07 Million | 1.00 | - |
| Financing Cash Flow | 355.18 Million | 400.47 Million | 731.89 Million | 151.78 Million | 3.74 Million | -300.32 Million |
| Debt repayment | -355.18 Million | -135.87 Million | -707.86 Million | -56.78 Million | -3.74 Million | -358.82 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 264.6 Million | - | 95 Million | - | 58.5 Million |
| Other Financing Activities | -1000.00 | - | 24.03 Million | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -21.25 Million | -143.76 Million | 198.77 Million | -13.62 Million | -62.54 Million | - |
| Inventory | -84.02 Million | -21.68 Million | -185.27 Million | -65.65 Million | 45.78 Million | 438.53 Million |
| Other working capital | -278.57 Million | -163.61 Million | -307.12 Million | -61.4 Million | 175.72 Million | 451.67 Million |
| Cash at beginning of period | 13.65 Million | 4.5 Million | 2.39 Million | 28.93 Million | 14.92 Million | 17.04 Million |
| Cash at end of period | 7.19 Million | 13.65 Million | 4.5 Million | 2.39 Million | 28.93 Million | 14.92 Million |
| Capital Expenditure | -43.33 Million | -144.75 Million | -578.56 Million | -10.44 Million | - | -33.96 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -6.45 Million | 9.14 Million | 2.11 Million | -26.54 Million | 14.01 Million | -2.12 Million |
| Free Cash Flow | -368.01 Million | -438.57 Million | -845.61 Million | -180.79 Million | 6.05 Million | 293.99 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -11.86 Million | -4.51 Million | 2.17 Million | -15.09 Million | -22.12 Million | -14.52 Million |
| Depreciation & Amortization | 72.97 Million | 18.13 Million | 18.87 Million | 18.01 Million | 73.87 Million | 18.41 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -383.85 Million | - | - | - | -329.07 Million | - |
| Other non-cash items | 249.28 Million | 22.65 Million | -18.87 Million | -18.01 Million | 296.71 Million | -18.41 Million |
| Investing Cash Flow | -36.96 Million | - | - | - | -97.51 Million | - |
| Investments in PPE | -43.33 Million | - | - | - | -144.75 Million | - |
| Acquisitions | 6.2 Million | - | - | - | 44.59 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 163 Thousand | - | - | - | 698 Thousand | - |
| Other Investing Activities | - | - | - | - | 1.95 Million | - |
| Financing Cash Flow | 355.18 Million | - | - | - | 400.47 Million | - |
| Debt repayment | -355.18 Million | - | - | - | -135.87 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | 264.6 Million | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -21.25 Million | - | - | - | -143.76 Million | - |
| Inventory | -84.02 Million | - | - | - | -21.68 Million | - |
| Other working capital | -278.57 Million | - | - | - | -163.61 Million | - |
| Cash at beginning of period | 13.65 Million | 4.34 Million | 2.17 Million | 13.65 Million | 4.5 Million | 28.18 Million |
| Cash at end of period | 7.19 Million | 40.62 Million | 4.34 Million | -15.09 Million | 13.65 Million | 13.65 Million |
| Capital Expenditure | -43.33 Million | - | - | - | -144.75 Million | - |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -6.45 Million | 36.27 Million | 2.17 Million | -28.74 Million | 9.14 Million | -14.52 Million |
| Free Cash Flow | -368.01 Million | 36.27 Million | 2.17 Million | -15.09 Million | -438.57 Million | -14.52 Million |
PGID
TBN
RECV3
SESPF
SUNPHARMA
CCR